Mind Medicine (MindMed) (MNMD) News Today $7.63 -0.55 (-6.72%) Closing price 04:00 PM EasternExtended Trading$7.65 +0.02 (+0.26%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Should You Sell?February 21 at 8:53 PM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Time to Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Should You Sell?February 19 at 10:56 PM | marketbeat.comMind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on WednesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Wednesday, February 26.February 19 at 3:38 AM | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedFebruary 16, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?February 15, 2025 | marketbeat.comWhy Mind Medicine Stock Is Skyrocketing TodayFebruary 14, 2025 | fool.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 9% - Should You Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 9% - Time to Sell?February 7, 2025 | marketbeat.comAnalysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been given an average rating of "Buy" by the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy recommendation and three havFebruary 7, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?February 6, 2025 | marketbeat.comMind Medicine (MNMD) Gets a Buy from H.C. WainwrightFebruary 5, 2025 | markets.businessinsider.comMind Medicine trading higher after zerohedge compares to OkloFebruary 5, 2025 | markets.businessinsider.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 5.5% Higher - What's Next?February 5, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading Volume - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?February 4, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for MNMD FY2029 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - HC Wainwright issued their FY2029 EPS estimates for Mind Medicine (MindMed) in a note issued to investors on Friday, January 31st. HC Wainwright analyst P. Trucchio anticipates that the company will post earnings per share of $2.84 for thFebruary 4, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus recommendation of "Buy" from the thirteen research firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and three haveFebruary 4, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?February 3, 2025 | marketbeat.comAnalysts Issue Forecasts for MNMD FY2029 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Friday, January 31st. HC Wainwright analyst P. Trucchio forecasts that the company wFebruary 3, 2025 | marketbeat.comH.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)January 31, 2025 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD)HC Wainwright reissued a "buy" rating and issued a $55.00 price target on shares of Mind Medicine (MindMed) in a report on Friday.January 31, 2025 | marketbeat.comLeerink Partnrs Has Bearish Outlook for MNMD Q4 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q4 2024 earnings estimates for shares of Mind Medicine (MindMed) in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that theJanuary 31, 2025 | marketbeat.comMind Medicine doses first patient in Panorama studyJanuary 30, 2025 | markets.businessinsider.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedJanuary 30, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for MNMD Q1 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman forecasts that the compJanuary 30, 2025 | marketbeat.comMindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety DisorderJanuary 30, 2025 | businesswire.comMindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' CallJanuary 29, 2025 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Evercore ISIEvercore ISI assumed coverage on shares of Mind Medicine (MindMed) in a report on Tuesday. They issued an "outperform" rating and a $23.00 target price on the stock.January 29, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Still a Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - What's Next?January 28, 2025 | marketbeat.comEvercore ISI sets $23 target on MindMed stock, sees potentialJanuary 28, 2025 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Evercore ISIEvercore ISI started coverage on Mind Medicine (MindMed) in a report on Tuesday. They issued an "outperform" rating and a $23.00 price objective for the company.January 28, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - Here's What HappenedJanuary 17, 2025 | marketbeat.comBarclays PLC Buys 91,271 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Barclays PLC lifted its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 203.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 136,098 shares of the company's stock after buying an additionalJanuary 16, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating and three have given a strong bJanuary 10, 2025 | marketbeat.comWhy Mind Medicine Stock Is Soaring TodayJanuary 7, 2025 | fool.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% Higher - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.8% - Time to Buy?January 6, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7% - Should You Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3.7% - Time to Sell?January 3, 2025 | marketbeat.comGeode Capital Management LLC Has $9.55 Million Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Geode Capital Management LLC grew its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 10.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,677,702 shares of the company's stock after purcJanuary 2, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Acquired by Barclays PLCBarclays PLC boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 203.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 136,098 shares of the company's stock after purchasing an additional 91,271 shares during the perioJanuary 1, 2025 | marketbeat.comCarrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockDecember 28, 2024 | insidertrades.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CAO Sells $16,888.39 in StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CAO Carrie Liao sold 2,273 shares of Mind Medicine (MindMed) stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $7.43, for a total transaction of $16,888.39. Following the transaction, the chief accounting officer now directly owns 97,270 shares in the company, valued at $722,716.10. This trade represents a 2.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.December 27, 2024 | marketbeat.comInsider Selling: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Insider Sells 6,643 Shares of StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) insider Dan Karlin sold 6,643 shares of Mind Medicine (MindMed) stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $7.43, for a total transaction of $49,357.49. Following the completion of the transaction, the insider now directly owns 338,013 shares in the company, valued at $2,511,436.59. The trade was a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.December 27, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in StockMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) CEO Robert Barrow sold 19,106 shares of the company's stock in a transaction that occurred on Thursday, December 26th. The shares were sold at an average price of $7.43, for a total transaction of $141,957.58. Following the completion of the sale, the chief executive officer now directly owns 526,666 shares of the company's stock, valued at $3,913,128.38. The trade was a 3.50 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.December 27, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 8.5% - Time to Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 8.5% - What's Next?December 27, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down - Time to Sell?December 26, 2024 | marketbeat.comChardan Capital Initiates Coverage of Mind Medicine (MNMD) with Buy RecommendationDecember 20, 2024 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Chardan CapitalChardan Capital started coverage on Mind Medicine (MindMed) in a report on Friday. They issued a "buy" rating and a $20.00 price target on the stock.December 20, 2024 | marketbeat.comWellington Management Group LLP Purchases 109,152 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Wellington Management Group LLP raised its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 142.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,722 shares of the company's stock aftDecember 20, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 4.9% - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.9% Higher - Here's WhyDecember 18, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Receives Outperform Rating from OppenheimerOppenheimer reaffirmed an "outperform" rating and set a $20.00 price target on shares of Mind Medicine (MindMed) in a research report on Tuesday.December 17, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation and three have issuDecember 16, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3% - Time to Sell?November 29, 2024 | marketbeat.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.530.60▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼54▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOR News TWST News VCEL News CPRX News MLTX News MRUS News BEAM News IBRX News ARWR News HCM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
